US 11840497
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted A61PA61P21/00A61P25/00
Quick answer
US patent 11840497 (4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases) held by PTC THERAPEUTICS, INC. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/16, A61P27/00